Increasing Cancer Incidence Driving Growth in the Chemotherapy Market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Chemotherapy Market By The End Of 2030?

The chemotherapy market has witnessed rapid expansion in recent years. This market is forecast to increase from $37.27 billion in 2025 to $41.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. Historically, this market’s growth can be attributed to the rising prevalence of cancer, increased government expenditure on healthcare, advancements in chemotherapeutic drugs, the expansion of hospital infrastructure, and the adoption of intravenous chemotherapy.

The chemotherapy market size is poised for substantial expansion in the coming years. It is projected to reach $68.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth during the forecast period is fueled by several factors, including the increasing reach of precision medicine, advancements in targeted therapies, growing understanding of home-based chemotherapy options, the incorporation of digital health solutions, and a rising need for combination therapies. Significant trends during this period are anticipated to encompass customized chemotherapy regimens, the adoption of oral chemotherapy, the creation of combination drug therapies, the provision of home-based chemotherapy, and sophisticated infusion device technologies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Which Market Drivers Are Supporting The Expansion Of The Chemotherapy Market?

A rising incidence of cancer is anticipated to stimulate the expansion of the chemotherapy market. Cancer is characterized by the uncontrolled proliferation of certain body cells which subsequently spread to other regions. Chemotherapy involves the application of potent chemical agents, individually or in conjunction, to combat cancer by eradicating rapidly multiplying cancerous cells. Consequently, the growing number of cancer cases will elevate the need for chemotherapy treatments. As an illustration, the World Health Organization, a specialized agency of the United Nations situated in Switzerland, indicated in February 2024 that the year 2025 is forecast to see over 35 million new cancer diagnoses, marking a 77% surge from the approximately 20 million cases recorded in 2022. Thus, the expanding prevalence of cancer is a significant impetus for the chemotherapy market.

Which Segment Classifications Shape The Chemotherapy Market?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

How Are Trends Impacting The Chemotherapy Market?

Major companies within the chemotherapy market are increasingly forming strategic alliances to enable the market entry of innovative medical devices designed to support chemotherapy services. These collaborations aim to utilize each party’s unique strengths and resources to accelerate advancements in cancer treatment, improve patient health outcomes, and address existing medical needs. For example, in March 2023, EVERSANA, a US-based provider of global services to the life sciences industry, partnered with ChemoMouthpiece LLC, a US-based medical device company, to facilitate the introduction and commercialization of its medical device, the Chemo Mouthpiece, to assist oncology patients across the United States. The Chemo Mouthpiece is an intraoral ice pack that delivers cryotherapy directly to the oral cavity of patients undergoing chemotherapy. Its purpose is to prevent and alleviate oral mucositis, a frequent and extremely painful side effect of chemotherapy.

Which Companies Are Expanding Their Footprint In The Chemotherapy Market?

Major companies operating in the chemotherapy market are GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Read the full chemotherapy market report here:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

How Is The Chemotherapy Market Distributed Across Key Geographic Regions?

North America was the largest region in the chemotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Chemotherapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9219&type=smp

Browse Through More Reports Similar to the Global Chemotherapy Market 2026, By The Business Research Company

Chemotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Chemotherapy At Home Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-at-home-services-global-market-report

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795